Guidance and quality standards In consultation
Showing 1 to 4 of 4
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Danicopan as an add-on treatment to a C5 inhibitor for treating extravascular haemolysis in adults with paroxysmal nocturnal haemoglobinuria [ID5088] | Draft guidance | Technology appraisal guidance | |
Tirzepatide for managing overweight and obesity [ID6179] | Draft guidance | Technology appraisal guidance | |
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments [ID6298] | Draft guidance | Technology appraisal guidance | |
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] | Draft guidance | Technology appraisal guidance |